Constantly being attached to home medical devices is overwhelming, but columnist Anna Jeter is also grateful for the ...

The FDA approved a Phase 2b trial of CS1, a new PAH therapy being tested for its impact on lung vessel resistance and ...

People with CTEPH and higher PAWP may see fewer gains from BPA, though safety and survival remain similar, a study shows.

People with CTEPH and higher PAWP may see fewer gains from BPA, though safety and survival remain similar, a study shows.

Scientists found altered activity of the PUM1 protein plays a key role in pulmonary hypertension development, making it a PH ...

Tiakis Biotech is preparing for a Phase 2 U.S. trial of tiprelestat for PAH after completing a data package required for ...

The American Lung Association is the leading organization working to save lives by improving lung health and preventing lung disease through education, advocacy and research.

When you live with a chronic and complex illness, complications and side effects from the medications to treat it are always lurking around the corner — even in the most stable of times. The more ...

A mouse study shows overproduction of the naturally occurring hormone adrenomedullin reduced lung injury and PH in experimental BPD-PH.

Scientists identified two proteins as biomarkers of CTEPH severity and progression, a discovery that could pave the way for future treatment.

Pulmonary hypertension (PH) is a rare but life-threatening disease that affects the pulmonary arteries, making them narrow and thick. The vessels, which are responsible for transporting blood from the ...